Acesulfame-K (Ace-K): Independent Evidence on Cancer Risk & Safety
The unreplicated cancer cohort signal — what it means. Independent human-trial evidence, funding traced, evidence graded.
Evidence-graded research on diabetes and blood-sugar control — what the systematic reviews and trials really show about diet, supplements and metabolic health.
The unreplicated cancer cohort signal — what it means. Independent human-trial evidence, funding traced, evidence graded.
Saccharin intake limits, cancer-history assessments, small glucose and microbiome trials, observational cognition findings, and funding and purity limits.
Human sucralose trials, glucose and microbiome findings, cancer-study limits, FDA and EFSA safety assessments, and reported funding and conflicts.
Aspartame evidence on cancer, cognition, glucose and PKU, with regulatory intake limits, study limitations and reported funding conflicts.
Small acute trials do not establish diabetes treatment or sustained weight loss. JECFA set a temporary mogroside V limit in 2026; food status and composition depend on the preparation.
Stevia forms, intake limits and human glucose, blood-pressure and microbiome studies, with trial limitations and reported funding conflicts.
Berberine studies suggest short-term glucose and lipid-marker changes, but do not establish a prescription-drug substitute. Formulation, funding, trial quality and medication interactions matter.
Review selected diabetes supplements, with glucose-marker findings, trial limitations, source funding and medicine-specific safety precautions.
Key takeaways A Cochrane review of 12 RCTs (5,238 participants) found combined diet plus physical activity cut type 2 diabetes incidence with a risk ratio of 0.57 versus standard care — about a 43% reduction in high-risk adults. The Diabetes Prevention Program showed intensive lifestyle change (targeting 7% weight loss and 150 min/week of activity) … Read more
Vitamin D supports bone and mineral health. D3 generally raises blood levels more than D2; disease-prevention benefits depend on the population. Compare forms, dosing guidance, interactions and funding limitations.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.